Pegylated (40 kda) interferon alfa-2A (PEGASYS®) in new combination therapies: a report of a randomized, multicenter efficacy and safety study

2001 ◽  
Vol 34 (0) ◽  
pp. 143 ◽  
Author(s):  
A Di Bisceglie
Keyword(s):  
Interferon Alfa ◽  
New Combination ◽  
Efficacy And Safety ◽  
Combination Therapies ◽  
Safety Study

Pegylated (40 KDA) interferon alfa-2a (PEGASYS®) in new combination therapies: a report of a randomized, multicenter efficacy and safety study

2001 ◽  
Vol 34 ◽  
pp. 143 ◽  
Author(s):  
A.M. Di Bisceglie ◽  
D.E. Bernstein ◽  
V.R. Rustgi ◽  
N. Gitlin ◽  
L.J. Jeffers ◽  
...  
Keyword(s):  
Interferon Alfa ◽  
New Combination ◽  
Efficacy And Safety ◽  
Combination Therapies ◽  
Safety Study

New combination therapies for castration-resistant prostate cancer

2019 ◽  
Author(s):  
Mitchell G Lawrence ◽  
Laura H Porter ◽  
Daisuke Obinata ◽  
Shahneen Sandhu ◽  
Luke A Selth ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
New Combination ◽  
Combination Therapies ◽  
Castration Resistant Prostate Cancer ◽  
Castration Resistant
Sign in / Sign up

Export Citation Format

Share Document